Company intelligence / Profile preview
Valeant Pharmaceuticals
Laval, Quebec, Canadabauschhealth.com ↗
- Ownership
- Public · BHC
- Employees
- ~21000
- Development stage
- Commercial
01
Overview
Valeant/Bausch Health has a broad commercial portfolio in eye health and dermatology. The company’s clinical results are not detailed in the search results but it markets numerous approved products globally.
- Therapeutic areas
- OtherDermatologyOphthalmologyNeurologyInfectious Diseases
- Modalities
- Small moleculesBiologicsNutraceutical/vitamin supplementContact lens/lens care productSurgical device/intraocular lens
- Industry
- Biotech
02
Drug pipeline
48 assets47 more assets in the full pipeline.
Beyond the preview
Go deeper on Valeant Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Valeant Pharmaceuticals.